Alnylam Pharmaceuticals’ Post

Redefine your CITE-Seq research by expanding its power to intracellular proteins. With our new Intracellular CITE-Seq Assay using BD® AbSeq Antibody-Oligos you can simultaneously detect RNA, surface proteins and intracellular proteins (such as cytokines and transcription factors) to get a full profile of your cells in one experiment like never before. Learn more here: 👉 https://lnkd.in/eUvMfUWT For Research Use Only. Not for use in diagnostic or therapeutic procedures. #IntracellularCITEseq #SingleCellMultiomics #BDRhapsody #BDBiosciences  

Intracellular protein detection from single cells? With whole transcriptome sequencing and cell surface protein detection? And with full length TCR/BCR sequencing? And sample multiplexing? YES, with Rhapsody platform. Maximise single cell data collection from your precious samples. #singlecellanalysis #multiomics #Immunology #CITE-seq

Weekly newsletter about CRISPR #crisprtechnology #geneticengineering #genetictesting #crisprcas9

𝐀𝐧𝐨𝐭𝐡𝐞𝐫 𝐅𝐫𝐢𝐝𝐚𝐲, 𝐚𝐧𝐨𝐭𝐡𝐞𝐫 𝐩𝐚𝐜𝐤𝐞𝐝 𝐧𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫 𝐟𝐫𝐨𝐦 𝐂𝐑𝐈𝐒𝐏𝐑 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐍𝐞𝐰𝐬! ✂ Exciting results from Stephanie Cherqui at UC San Diego and colleagues at Sanford Consortium for Regenerative Medicine, who demonstrate that excision of certain repeats in the FRX gene can rescue disease phenotypes in Friedreich’s ataxia iPSC-derived neurons. ✅ The European Commission approves CASGEVY™ for the treatment of sickle cell disease and beta thalassemia in individuals 12 years and older. 🤝 Intellia Therapeutics, Inc. and ReCode Therapeutics join forces to develop new gene-editing therapies for cystic fibrosis. Get all the news below 👇 https://lnkd.in/ezvnWxHA #crisprmedicinenews #crisprmedicine #geneediting #fda #crispr #raredisease #clinicalnews #crisprnews #crisprtrial Sangamo Therapeutics, Inc. CRISPR Therapeutics Fate Therapeutics Inc Precision BioSciences, Inc. Prime Medicine, Inc.

latest CRISPR news

The new Fragment Sequencing approach developed by researchers at ETH Zurich is opening up new insights into single-cell transcriptomics, and expanding the scope of what we know about cell-to-cell interaction, disease progression and tumorigenesis. Read our summary of the study to learn more : 👉 https://lnkd.in/dRQDGZ6N #BDBiosciences #SingleCellAnalysis #SingleCell #SpatialBiology #Rhapsody #BD 

The new Fragment Sequencing approach developed by researchers at ETH Zurich is opening up new insights into single-cell transcriptomics, and expanding the scope of what we know about cell-to-cell interaction, disease progression and tumorigenesis. Read our summary of the study to learn more : 👉 https://lnkd.in/dRQDGZ6N #BDBiosciences #SingleCellAnalysis #SingleCell #SpatialBiology #Rhapsody #BD 

🌱 R-BIO protects and maintains the native ⬆ Exosomes production  that participate in intercellular communication, facilitated by the transfer of mRNA, miRNAs, proteins such as cytokines and growth factors, as well as lipids from host cells and directing various cellular responses in target cells. #Exosomas #healthyskin #ecocosmetics #RenophaseBIO #Skinmicrobioma

Monoclonal antibody Prasinezumab shows promise in slowing rapid Parkinson's progression. In a recent study published in the journal Nature Medicine , a large, international team of researchers conducted an exploratory analysis to evaluate whether the monoclonal antibody prasinezumab, which had previously been observed to be effective in slowing the progression of motor-associated signs of Parkinson’s disease, did indeed show benefits in subgroups of Parkinson’s disease patients with faster progression of motor degeneration... Check out the full story 👉 https://zurl.co/BKpp (News Medical) #biotech #genetics

BD Rhapsody goes spatial 👀. Read a summary of the study at: https://lnkd.in/dRQDGZ6N #BDBiosciences #SingleCellAnalysis #SingleCell #SpatialBiology #Rhapsody #BD